Methods and formulations for treatment and/or prevention of blood-associated disorders
AssigneeTWi Biotechnology, Inc.
InventorsChih-Kuang Chen, Jing-Yi Lee, Wei-Shu Lu, Carl Oscar Brown, III
Life of this patent
Estimating the term…
Abstract
A method of treating and/or preventing blood-associated disorders is provided. Also provided is a method of treating and/or preventing hemophilic arthropathy and/or hemochromatosis arthropathy in a subject.
Claims21
A method for the treatment and/or prevention of blood-associated disorders in subjects, comprising administering to the subjects in need of such treatment and/or prevention a therapeutically effective amount of a compound selected from the group consisting of diacerein, rhein, monoacetylrhein, and pharmaceutically acceptable salts or esters or prodrugs thereof.
A method for the treatment and/or prevention of hemophilic arthropathy in a subject, comprising administering to the subject in need of such treatment and/or prevention a therapeutically effective amount of a compound selected from the group consisting of diacerein, rhein, monoacetylrhein, and pharmaceutically acceptable salts or esters or prodrugs thereof.
A method for the treatment and/or prevention of hemochromatosis arthropathy in a subject, comprising administering to the subject in need of such treatment and/or prevention a therapeutically effective amount of a compound selected from the group consisting of diacerein, rhein, monoacetylrhein, and pharmaceutically acceptable salts or esters or prodrugs thereof.
Dependencies are inferred from the claim text.